Quoted from http://www.philly.com/philly/business/20150225_Johnson___Johnson_loses_first_Risperdal_jury_trial.html
Johnson & Johnson loses first Risperdal jury trialPosted: Wednesday, February 25, 2015, 1:08 AM
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old autistic man from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal.
This was the first case related to the condition called gynecomastia that went to a jury, but thousands more lawsuits are lined up in Philadelphia, California, Missouri, and other locations.
J&J paid $2.2 billion in 2013 to settle federal and state criminal and civil charges related to illegal marketing of the drug, but that did not stop individual lawsuits related to adverse events.
[Article continues at original source]